Free tool
Diagnostics stocks
We cover 22 companies grouped under the Diagnostics theme. The median market value in the group is $7.43B. Across the group, the median move over the past trading day is +0.25%. 86% of the 22 with a 200-day average trade above it. Price change over the past year runs from −28.0% to +144.5% across the middle 80 percent of the group, with a median of +14.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
22 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| SHL.AX | Sonic Healthcare Limited | 20.12 AUD | −11.44% | −8.60% | −11.84% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.